Personalised Medicine Vetter's Germany Expansion Chikungunya Detection Brazil Healthcare Regulatory | e-Newsletter | www.pharmafocusasia.com | Archives | Advertise |
| | Articles | | Prospects for Personalised Medicines in the Asia-Pacific Region
Christopher Milne
Director
Personalised Medicine (PM) is the wave of the future, but will the waves be bathing the shores of Asia-Pacific with the same market force as they do on either side of the Atlantic? Personalised medicine, also called precision medicine, encompasses... |
Research Insights | | Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection In December of 2013, chikungunya virus (CHIKV), an alphavirus in the family Togaviridae, was introduced to the island of Saint Martin in the Caribbean, resulting in the first autochthonous cases reported in the Americas. As of January 2015, local and imported... | Projects | | Vetter invests 300 million Euro to expand and upgrade its manufacturing facilities in Germany Vetter has announced to invest approximately 300 million euros to expand and upgrade its manufacturing facilities over an estimated five-year period.The upgrades are being driven by a changing healthcare market that is affected by issues... | Reports | | Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)
Healthcare, Regulatory and Reimbursement Landscape - Brazil
Insomnia - Global Drug Forecast and Market Analysis to 2023 | | | |
|
e-Magazine| Subscribe | Unsubscribe | |
www.pharmafocusasia.com – a product of Ochre Media Pvt. Ltd. Ochre Media Pvt Ltd. Media Resource Centre, 2nd Floor, Oxford Plaza, Secunderabad - 500 003, Telangana, India Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555 |